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Development and Validation  
of the Vision-related Dizziness 
Questionnaire
Deborah Armstrong, Alison J. Alderson, Christopher J. Davey and David B. Elliott*
School of Optometry and Vision Science, University of Bradford, Bradford, United Kingdom
Purpose: To develop and validate the first patient-reported outcome measure (PROM) 
to quantify vision-related dizziness. Dizziness is a common, multifactorial syndrome that 
causes reductions in quality of life and is a major risk factor for falls, but the role of vision 
is not well understood.
Methods: Potential domains and items were identified by literature review and discus-
sions with experts and patients to form a pilot PROM, which was completed by 335 
patients with dizziness. Rasch analysis was used to determine the items with good 
psychometric properties to include in a final PROM, to check undimensionality, differen-
tial item functioning, and to convert ordinal questionnaire data into continuous interval 
data. Validation of the final 25-item instrument was determined by its convergent validity, 
patient, and item-separation reliability and unidimensionality using data from 223 patients 
plus test–retest repeatability from 79 patients.
results: 120 items were originally identified, then subsequently reduced to 46 to form 
a pilot PROM. Rasch analysis was used to reduce the number of items to 25 to pro-
duce the vision-related dizziness or VRD-25. Two subscales of VRD-12-frequency and 
VRD-13-severity were shown to be unidimensional, with good psychometric properties. 
Convergent validity was shown by moderately good correlations with the Dizziness 
Handicap Inventory (r = 0.75) and good test–retest repeatability with intra-class correla-
tion coefficients of 0.88.
conclusion: VRD-25 is the only PROM developed to date to assess vision-related 
dizziness. It has been developed using Rasch analysis and provides a PROM for this 
under-researched area and for clinical trials of interventions to reduce vision-related 
dizziness.
Keywords: vision-related dizziness, dizziness, patient-reported outcome measure, questionnaire, rasch analysis
inTrODUcTiOn
Dizziness is common in older people (~30% in patients over 65 years of age) (1), can have significant 
negative effects on quality of life (2, 3), and is a major risk factor for falls (4). Although vestibular 
disease and central vascular disease are the most commonly reported diagnoses in secondary/
tertiary care (1, 5) and primary care (1), respectively, the prevalence of specific causes of dizziness 
varies hugely (1, 6) and dizziness is a multifactorial geriatric syndrome (1–3, 6) like falls. Causes 
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include vestibular disease, psychiatric disorders, vascular disease 
including hypotension, polypharmacy, medication side effects, 
Parkinson’s disease, and visual impairment. There are several 
subcategories (7) of dizziness: disequilibrium, light-headedness, 
pre-syncope, and vertigo and each may be related to different 
diagnoses. Visual impairment (1) and changes in refractive cor-
rection (8) likely have a role in the dizziness subcategories of ver-
tigo (the feeling that either the individual or their surroundings 
are spinning) via the vestibulo-ocular reflex and disequilibrium 
(the feeling that an individual cannot keep their balance when 
they are standing still) via the influence of visual function on 
postural stability (9).
Although the literature investigating the link between vision 
and dizziness is relatively small, the authors of a systematic 
review concluded that large-sample, well-designed epidemio-
logical studies found that self-reported visual impairment was a 
significant independent predictor of dizziness (10). In addition, 
a recent cohort study found that dizziness reduced following 
first-eye cataract surgery by an amount linked to the improve-
ment in best eye visual acuity, but was increased by changes in 
oblique astigmatic refractive correction (11). Finally, patients 
with Visual Vertigo report dizziness that is triggered by visual 
motion such as when walking in supermarket aisles, driving, and 
watching moving scenes. This condition is thought to be due to 
overreliance on visual control after vestibular disease or other 
insult (12, 13).
There are currently no patient-reported outcome measures 
(PROMs) that assess vision-related dizziness (3). The Visual 
Vertigo Analog Scale (14) is a nine-item visual analog scale to 
assess the intensity of symptoms for patients with Visual Vertigo 
which was developed using classical test theory. It is restricted to 
assessment of the one condition of Visual Vertigo. Most of the 
commonly used dizziness PROMs, such as the current stand-
ard, the Dizziness Handicap Inventory (DHI), were developed 
for patients with vestibular disease (15). In addition, the great 
majority of PROMs that target dizziness used traditional classi-
cal test theory questionnaire development methods (3, 15) and a 
systematic review concluded that there were no validated PROMs 
for the study of age-related vestibular loss in clinical trials (15).
Preferred for the development of PROMs are the psycho-
metric methods of item response theory that includes Rasch 
analysis (16–20). These have many advantages over classical test 
theory such as the conversion of ordinal data from questionnaire 
responses into continuous interval data, allowing linear measure-
ment and determining dimensionality (16, 18). Indeed, tradi-
tionally developed PROMs have been re-engineered and scored 
using Rasch analysis when assessing vision-related quality of life 
(19, 20). Rasch analysis has been used to develop a short-form (13 
items) of the 25-item DHI (21) and we have used this PROM in a 
study of dizziness before and after cataract surgery (11). However, 
it was developed to assess patients with vestibular disease, with 6 
of 13 items being directed at symptoms from such patients (items 
relate to dizziness when getting in and out of bed, turning over 
in bed, bending over, quick head movements, looking up, and 
walking in the dark) with just three items being related to vision 
in some way (dizziness when reading, walking down the aisle 
of a supermarket, and walking on the sidewalk, the latter two 
being well-known triggers for Visual Vertigo) and is limited in its 
assessment of vision-related dizziness.
The aim of this study was to develop and validate using Rasch 
analysis the first PROM to quantify vision-related dizziness. 
This would provide a PROM for clinical research in the under-
researched area of vision-related dizziness and for clinical trials 
of vision and refractive interventions aimed to reduce dizziness.
MaTerials anD MeThODs
PrOM Development
Patient-reported outcome measure development and validation 
generally followed the recommendations by Pesudovs et al. (16). 
This study was carried out in accordance with the recommenda-
tions of the Research Ethics Committees of both the University of 
Bradford and the UK National Health Service (UK EC1843 and 
IRAS 180272). The protocol was approved by these committees. 
All subjects gave written informed consent in accordance with 
the Declaration of Helsinki.
Domain and item identification
Patient-reported outcome measures relating (separately) to 
visual disability, vision-related quality of life, and dizziness were 
identified from a comprehensive search of the literature and were 
examined to identify domains and items that could be related to 
vision-related dizziness. The structure of the Rasch-developed 
visual symptom PROM, Quality of Vision (22), with its three 
subscales of the “frequency,” “severity,” and “bothersomeness” 
of symptoms, was incorporated into the item identification 
process. We previously found that a “frequency” based ques-
tionnaire developed to assess spectacle adaptation symptoms 
(which included dizziness), appeared to be limited by a lack of 
assessment of the severity/bothersomeness of symptoms (23). 
Response categories of “so severe/bothersome I have reduced 
doing this” and “so severe/bothersome I have stopped doing 
this” provided assessment of the activity limitation aspects of 
dizziness. The domains and items identified by the literature 
search and further identification of other domains and items 
were discussed with nine experienced clinicians and structured 
interviews with patients who self-reported problems due to 
dizziness. The clinicians included two consultant geriatricians 
(in the UK, a consultant physician typically has at least 10 years 
post registration experience and is similar to a US attending 
physician) and a specialist physiotherapist with 10+years of 
experience, a consultant ophthalmologist, two optometrists 
(authors David B. Elliott and Alison J. Alderson, with 20+years 
of clinical experience), two ENT consultants, and a hospital 
specialist audiologist with 20+years of experience. The nine 
patients were recruited from the staff of the University via an 
email request and patients from local vision and falls clinics and 
included patients with self-reported vision-related dizziness 
linked to age-related cataract (two) multifocal spectacle lens 
use (two), large spectacle power changes (one), one patient 
with Visual Vertigo and three patients with vestibular disease 
who helped differentiate between dizziness linked to vestibular 
disease and vision-related issues. Patients were recruited and 
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interviewed until saturation of themes had been reached. They 
were asked about the important quality of life issues that were 
affected by their dizziness.
item reduction
Items deemed to be irrelevant, duplicate, or unhelpful were then 
discarded by a three-step process. First, by separate consultation 
with the clinicians described above. Second, by a focus group of 
six of those clinicians. Third, by a focus group of four patients 
(age range 35–79 years, two females) who were recruited via an 
email request from the staff of the University and patients at the 
University Eye Clinic and reported vision-related dizziness (two 
diagnosed with Visual Vertigo, two with a history of dizziness due 
to multifocal spectacles).
cognitive interviews
After item reduction, the patient focus group provided cognitive 
interview information by discussing the readability and ease 
of comprehension of the items and response categories. This 
resulted in appropriate wording changes to some questions and 
the addition of clarification of what was meant by each response 
category. For example, the category of “Very Often” could mean 
different frequencies to different people, so the focus group sug-
gested that adding “(e.g., 2–6 times per week)” would make it 
easier for participants to understand what was meant.
Pilot Questionnaire
As the diagnosis of dizziness is multifactorial and challenging and 
many patients are unaware of whether vision is part of the etiol-
ogy of their dizziness (1), the inclusion criteria for completion of 
the pilot questionnaire included any patient with self-reported 
dizziness who was over 18 years and had suffered from dizziness 
in the past month. An electronic version of the questionnaire 
was created using Wufoo (http://www.wufoo.com) and indicated 
that a questionnaire was being developed to quantify vision-
related dizziness. Patients gave their consent by submitting a 
completed online questionnaire. The research was publicized via 
e-newsletters and social media to international dizziness-related 
support groups (e.g., the Vestibular Disorders Association, 
Vertigo & Meniere’s disease support group), national support 
centers for older people (e.g., Women’s Institute of the UK and 
Canada; Age UK), and a wide range of regional UK older peoples’ 
forums and support groups. Paper copies of the pilot instrument 
were made available to patients with dizziness in regional Falls, 
Vestibular Diseases and Audiology Clinics, and informed consent 
was gained from patients who completed the paper version of 
the questionnaire. The pilot questionnaire was available for 
completion on the Wufoo site between April 4, 2016 and June 21, 
2016. The minimum target sample size was 250 (24). Additional 
information collected included respondent age, sex, cause of diz-
ziness, and whether they had fallen in the last 6 months.
Data analysis of Pilot Questionnaire
Rasch analysis (Winsteps version 3.91.0; Winsteps, Chicago, 
IL, USA) using an Andrich rating scale model assessed the 
response categories and individual person data. Individual 
items from the pilot data were examined in terms of their fit to 
the Rasch model of Infit and Outfit [values outside the range 
of 0.60–1.40; this is slightly more lenient than the 0.70–1.30 
suggested by Pesudovs et  al. (16) and follows Wright and 
Linacre] (25), normality of the distribution including ceiling 
and floor effects, proportion of missing data (>33%) (26), and 
the distance of the item mean response to the mean participant 
response (16). Poorly fitting items were removed iteratively 
with the model being reanalyzed after each item elimination. 
If the fit of the model was negatively affected by the removal of 
an item, that item was re-introduced. The process was repeated 
until all items fitted well and the content of the final instrument, 
the vision-related dizziness (VRD-25) PROM, was determined. 
Unidimensionality of VRD-25 was checked with principal 
components analysis. Any subscales identified by the principal 
components analysis were then reanalyzed using Rasch analysis 
to ensure robust psychometric properties. Dimensionality of 
VRD-25 was assessed using principal components analysis to 
test for unidimensionality and differential item functioning 
(DIF) was used to assess whether different groups (such as 
younger vs. older participants, males vs. females) answered the 
questions differently. A significant difference was taken as the 
Rasch–Welch DIF contrast being >0.5 logits and the t value 
being ≥ ±2 (27).
assessment of VrD Performance
Electronic versions of the VRD-25 and the DHI, were created 
using Wufoo (http://www.wufoo.com) and publicized via the 
same e-newsletters and social media used previously. Respondents 
were asked to complete both questionnaires and they were avail-
able on the Wufoo site between November 1, 2016 and February 
22, 2017. Performance of the VRD-25 was assessed using conver-
gent validity, person, and item-separation reliability, test–retest 
agreement, dimensionality using principal components analysis, 
and DIF using Rasch analysis.
Convergent validity was assessed by the amount of correla-
tion with a related measure, the most commonly used dizziness 
PROM, the DHI (15). Acceptable performance would be a cor-
relation coefficient between VRD and DHI between 0.30 and 0.90 
(16). This is the first step in evaluating validity of VRD and future 
studies may assess other aspects of validity.
Discriminative ability was assessed using Rasch person and 
item-separation reliabilities. These measure how well the items of 
the instrument differentiate between people with different levels 
of dizziness. Good separation indices indicate that the instrument 
can discriminate between people with different levels of dizziness. 
For example, a person-separation index of >2.0 indicates that 
the instrument can discriminate between people with high and 
low symptom levels and good performance would be reliability 
coefficients ≥0.80 (16).
Test–retest reliability of VRD was determined by re-
administering VRD (and DHI for comparison) after 2–4 weeks 
to those participants who had consented. Good performance 
would be a test–retest intra-class correlation coefficient ≥0.80 
(16). Correlation analyses were performed using SPSS statistics 
for Windows (version 23.0; IBM Corp., Armonk, NY, USA).
FigUre 1 | A flowchart showing the development and validation process for the 25-item vision-related dizziness (VRD-25) patient-reported outcome measure.
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resUlTs
The development process is summarized in Figure 1.
Domain and item identification
One hundred twenty items under three domains of symptoms, 
activity limitation, and psychosocial issues were identified. Items 
included the frequency and severity of dizziness related to reading, 
walking alongside a busy road, down the aisle of a supermarket, 
on sloping surfaces, up or down stairs, moving around the home, 
stepping onto an escalator, watching moving scenes on TV, watch-
ing a scrolling computer screen, when driving a car, and looking 
from a height; plus psychosocial issues due to dizziness of dif-
ficulties concentrating, feeling confused, anxious or upset, people 
thinking you are intoxicated and being afraid to leave the home.
item reduction
Questions that related to “light-headedness” (most often used 
to describe symptoms associated with postural hypotension) 
were removed from the list of possible items, as the results of a 
systematic review of the link between vision and dizziness sug-
gested these were not relevant to vision-related dizziness (10). 
Initially, items included three versions relating to the frequency, 
severity, and bothersomeness of symptoms (22). However, the 
clinicians and patient focus group felt that if a patient found their 
dizziness to be “bothersome,” they would rate it as “severe” and 
they thought the latter term was more understandable so that 
“bothersome” response categories were removed. In addition, 
the original Quality of Vision instrument reported the lowest 
person-separation reliability and construct validity for the both-
ersomeness scale (22). A five-point Likert-type response scale 
for responses was used to minimize respondent burden while 
maximizing measurement of the construct (28). The resulting 
46-item instrument, including three domains of symptoms 
(17 items), activity limitation (17 items), and psychosocial issues 
(12 items), formed the pilot questionnaire.
Pilot study Questionnaire
The pilot instrument was completed by 351 participants with a 
mean age of 57 ± 14, range 20–94 years; 79% were female; 95% 
completed online; 75% were from North America, 21% from 
Europe, and 4% other; the most common self-reported causes 
of participants’ dizziness were Vestibular (including Ménière’s 
Disease, Vertigo, and Labyrinthitis) 58%, unknown 26%, visual 
5%, and other 11%; 38% had fallen in the last 6 months.
Each item and person’s responses were examined and 16 sets of 
individual respondent data were discarded as they were incomplete 
[>33% missing responses (26)] or reported not being dizzy in 
the previous month. All items provided less than 33% missing 
responses, and all were included in the analyses. Category pro-
bability curves were generated from the remaining sample of 335 
and suggested no redundancy of response categories and only 
minor differences between response categories 3 and 4 which 
were not alleviated by collapsing the two categories so that they 
were retained. The Rasch person-item map is shown in Figure 2. 
It shows the average positions of items on the right as numbers 
from Q1 to Q23 for both F (frequency) and S (Severity) items, 
with the items at the top being more rarely endorsed as they 
were only responded to positively by people who had high levels 
of dizziness. The respondents are on the left of the map with a 
# representing two respondents. Respondents at the top have 
more frequent and severe symptoms than those at the bottom. 
FigUre 2 | The Rasch person-item map from the 335 responses to the pilot questionnaire, with mean positions of items on the right and respondents on the left.
5
Armstrong et al. Vision-Related Dizziness Questionnaire
Frontiers in Neurology | www.frontiersin.org May 2018 | Volume 9 | Article 379
FigUre 3 | Scatterplots of Vision-related dizziness-severity (VRD-13s);  
(a) and VRD-frequency (VRD-12f); (B) scores vs. dizziness handicap 
inventory (DHI) scores.
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The person-separation and item-separation reliabilities were 
0.94 and 0.98, respectively. Using the procedure described in the 
methods, twenty-one (46%) poorly fitting items were iteratively 
removed, to leave VRD consisting of 25 items. VRD-25 is shown 
in Presentation S1 in Supplementary Material.
VrD-25 Validation
Differential item functioning (a test of item bias) showed no 
significant differences for age (above and below the median 
age of 57). Slight DIF differences were found between male and 
female respondents for three unconnected items and were not 
deemed sufficiently important to remove the item. The VRD-25 
provided an excellent person-separation reliability of 0.94 and 
item-separation reliability of 0.98, which are well above the level 
required for good performance of ≥0.80 (16).
Principal components analysis indicated that the data were not 
unidimensional, with 57% of the raw variance explained by the 
measure and the eigenvalue of the first contrast being 3.2 and above 
the cutoff value of 2.0 (27). Two components were indicated by 
principal components analysis and these clearly split into the items 
that related to the “severity” of the dizziness and its “frequency.” 
These two subscales were then assessed using Rasch analysis and 
principal components analysis. Both subscales of “frequency” 
(termed VRD-12f) and “severity” (VRD-13s) items were found 
to be unidimensional (VRD-12f 58%, VRD-13s 59% raw variance 
explained, all eigenvalues below 1.95). Rasch indices remained 
very good for all items (infit and outfit values within 0.60–1.40), 
person-separation reliabilities (VRD-12f: 0.88; VRD-13s: 0.90), 
and item-separation reliabilities (VRD-12f: 0.96; VRD-13s: 0.98).
VRD-25 and DHI were completed by a further 223 participants 
(mean age 48, SD 12 years; 83% female; 100% completed online; 
56% from North America, 29% from Europe including 26% UK, 
7% Oceania, and 8% other). VRD-12f and VRD-13s data were 
normally distributed (Kolmogorov–Smirnov, p > 0.10) but DHI 
data were not (p = 0.021). Rasch analysis indicated the following 
person-separation reliabilities (VRD-12f: 0.88; VRD-13s: 0.90) 
and item-separation reliabilities (VRD-12f: 0.97; VRD-13s: 0.96), 
with other psychometric properties similar to the pilot instrument 
data. Scatterplots of VRD-13s and VRD-12f vs. DHI are shown 
in Figure 3, showing Spearman correlation coefficients between 
the two of 0.75 (VRD-12f vs. DHI) and 0.76 (VRD-13s vs. DHI).
VRD-25 and DHI repeatability data was obtained from 
82 participants (mean age 51, SD 11  years; 90% female; 100% 
completed online; 54% from North America, 27% from Europe 
including 21% UK, 11% Oceania, and 8% other) and data from 
3 participants were discarded as they showed major changes in 
dizziness score (>33 on the 0–100 scales). The Bland–Altman 
95% repeatability values were ±13 (DHI), ±19 logits (VRD-12f), 
and ±14 logits (VRD-13s) (Figure  4). To allow comparison 
with earlier reports, intra-class correlation coefficients between 
test and retest data were calculated and found to be 0.92 (DHI), 
0.88 (VRD-12f), and 0.88 (VRD-13s). The mean time taken to 
complete the PROM was 6 (range 3–10) minutes.
DiscUssiOn
As expected, the VRD-25-item instrument was found to be 
multidimensional with two clear subscales, one containing items 
related to the frequency of vision-related dizziness issues and the 
other related to their severity. These two subscales were found to 
be unidimensional, which is a prerequisite before item responses 
can be summed to provide a total score (17, 28). Our previous 
experience (23) and that of others (22) is that the assessment 
of symptoms appears to need an assessment of both their fre-
quency and severity/bothersomeness. The VRD-25 subscales of 
frequency (VRD-12f) and severity (VRD-13s) were individually 
shown to have excellent person-separation reliability (>0.87) 
and item-separation reliability (>0.89) by Rasch analysis and 
well above the recommended level for good performance of 0.80 
(16). Convergent validity was determined by the association with 
the DHI and was found to be within the acceptable performance 
band of between 0.30 and 0.90 (16) (VRD-12f, r = 0.70; VRD-13s, 
r = 0.73). Test–retest repeatability of the VRD-25 was well above 
the good performance level of test–retest intra-class correlation 
coefficients (0.80) at 0.88 and 95% confidence limits of agreement 
were ±14 (VRD-13s) and ±19 logits (VRD-12f) and similar to 
the repeatability of the DHI (r =  0.92, ±13, respectively). The 
DHI repeatability data are similar to that reported by the develop-
ers of the instrument with morning–afternoon test–retest data 
(from which you might expect reduced variability compared to a 
2-week test–retest period) from 14 participants of ±18 limits of 
agreement and a test–retest correlation coefficient of 0.97.
A limitation of the study is that the participants who com-
pleted the pilot and final PROMs may not be representative of 
patients with vision-related dizziness. Indeed, 58% reported 
that the principal cause of their dizziness was Vestibular disease 
(including Ménière’s Disease, Vertigo, and Labyrinthitis) and only 
FigUre 4 | Bland–Altman plots of Vision-related dizziness-severity (VRD-13s); (a) and VRD-frequency (VRD-12f); (B) showing mean test–retest differences and 
95% confidence limits for 70 participants.
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5% reported their dizziness was mainly due to a vision problem. 
However, dizziness is multifactorial (1–3, 6) and vision plays a 
greater role in controlling balance when the vestibular system is 
impaired (29), so that any impairment in vision in patients with 
vestibular disease is likely to lead to increased dizziness. This is 
highlighted by the condition “Visual Vertigo” which is thought to 
be due to overreliance on visual control after vestibular disease or 
other insult (12, 13). In addition, the prevalence of vision-related 
dizziness may be underestimated (for example, patients may 
believe that their dizziness is due to a vestibular problem yet have 
Visual Vertigo) and there is little high quality epidemiological 
data investigating the link between visual impairment and diz-
ziness (10). It may be that once more is known about the visual 
contribution to dizziness, an improved vision-related dizziness 
PROM can be developed. The high percentage of respondents 
being female (79%) may be because dizziness is more common 
in women and particularly older women (2), who constituted the 
majority of our respondents. It may be that women are also more 
likely to be members of support groups such as those we targeted 
like the VDA, Pensioner forums, and of course, the Women’s 
Institute.
In summary, VRD-25 is the only PROM developed to date 
to assess vision-related dizziness. It has been developed using 
Rasch analysis and the two subscales of VRD-12 (frequency) and 
VRD-13 (severity) provided good psychometric properties, con-
vergent validity, and test–retest agreement. VRD-25 can be used 
to develop research into the link between dizziness and visual 
impairment and refractive correction and provides a PROM for 
clinical trials of vision and refractive interventions that could 
reduce dizziness.
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